Navigation Links
MTI-GlobalStem Launches PluriQ™ G9™ Gene Editing System and PluriQ™ G9™ Cloning Medium for Maximum Efficiency CRISPR Genome Editing in Pluripotent Stem Cells
Date:6/24/2016

Today, MTI-GlobalStem, a provider of optimized transfection reagents and protocols for human induced pluripotent stem (iPS) cells and other difficult to transfect cells, announces its launch of the PluriQ™ G9™ Gene Editing System and PluriQ™ G9™ Cloning Medium. The PluriQ™ G9™ Gene Editing System is a complete system for culturing and transfecting human pluripotent stem cells for gene editing via CRISPR/Cas 9 and other methods. The PluriQ™ G9™ Cloning Medium allows for single cell clonal expansion of pluripotent stem cells lines.

Benefits of the PluriQ™ G9™ Gene Editing System and PluriQ™ G9™ Cloning Medium

The system includes the G9™ Maintenance Medium and G9™ VTN Recombinant (vitronectin) coating for culturing human induced pluripotent (iPS) or embryonic stem (hES) cells in a manner that maximizes transfection with the included EditPro™ Stem Transfection Reagent to deliver genome editing constructs. EditPro™ Stem is optimized for delivery of CRISPR/Cas9 editing via DNA Cas9 vectors, Cas9 mRNA with DS DNA (G-block), Cas9 mRNA with tracr/guide RNA, or Cas9 protein with tracr/guideRNA. It is effective for delivery of TALEN and ZFN editing tools as well. iPS or hES cells, when grown on the G9™ VTN included in the system in G9™ Maintenance Medium, maintain their pluripotency in a monolayer culture that is ideal for even, high efficiency transfection when using EditPro™ Stem. The G9™ Versene is used as a gentle, easy, non-enzymatic method of passaging the cells and is scalable to higher throughput culture. PluriQ™ G9™ Cloning Medium supports single cell/well clonal selection for human iPS or human ES cell lines after gene-editing.

Dr. James Kehler VMD, PhD, Director of Scientific Alliances at MTI-GlobalStem, comments, “With such high efficiency delivery, as high as 90%, it is not necessary to electroporate, flow sort or include an antibiotic selection in the editing design. The flexibility to co-deliver DNA, RNA, and/or Protein with EditPro Stem makes it easy for researchers to use the best editing tools for their cells and applications.” He adds, “We have optimized the culture conditions, so that scientists don’t have to. Using the G9 system components together maximizes transfection efficiency, while maintaining high viability and pluripotency of human stem cells. By taking advantage of the gentle, single cell dissociation provided by Versene and using our G9™ Cloning Medium, researchers can simply dilute and plate 1 cell per well to establish and expand clonal lines of human iPSCs that maintain pluripotency. This technical achievement overcomes human pluripotent stem cells' propensity to die or differentiate when plated as single cells, and enables scientists to readily create clonal, genetically modified lines for their experiments."

Read the full story at http://www.prweb.com/releases/2016/06/prweb13505616.htm.


'/>"/>
Source: PRWeb
Copyright©2016 Vocus, Inc.
All rights reserved


Related medicine news :

1. MTI-GlobalStem Announces Collaboration for First Commercial In Vitro Test System for Human Neuroprotection in Proteopathic Diseases, Such As Alzheimer’s and Parkinson’s
2. InhaleLabs.com Launches to Help Medical Cannabis Users Compare Water Pipes
3. Mediaplanet Launches “Connected Health Care” Campaign Featuring Quality Health Ideas Inc.
4. AONN Launches Its Making the Case to Management Contest to Win Complimentary Membership and Registration to This Year’s Annual Conference
5. MDS Task Force Launches First Ever Genetic Mutation Database for Movement Disorders (MDSGene)
6. Splashtop Launches Classroom Assist Optimized for Microsoft Windows 10
7. National Ovarian Cancer Coalition Launches a New and Improved Website
8. GrassrootsHealth Launches Vitamin D Project Aimed at Improving Birth Outcomes in Missoula
9. Florida Hospital Carrollwood Launches Safe Patient Lifting Initiative
10. Get Real Health Launches Patient Engagement Tool for Saskatchewan Residents
11. American University of Antigua College of Medicine Launches New Scholarship
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/12/2017)... ... October 12, 2017 , ... ... treating sleep apnea using cutting-edge Oventus O2Vent technology. As many as ... disorder characterized by frequent cessation in breathing. Oral appliances can offer significant relief ...
(Date:10/12/2017)... ... October 12, 2017 , ... IsoComforter, Inc. ( https://isocomforter.com ), ... of an innovative new design of the shoulder pad. The shoulder pad provides ... while controlling your pain while using cold therapy. By utilizing ice and water that ...
(Date:10/12/2017)... ... October 12, 2017 , ... Information about ... intend to develop to enable prevention of a major side effect of chemotherapy ... especially in pediatric patients. For cisplatin, hearing loss is FDA listed on-label as ...
(Date:10/12/2017)... ... October 12, 2017 , ... Leading pediatric oncology experts at ... D.C., for the 49th Congress of the International Society of Paediatric Oncology ... the Center for Cancer and Blood Disorders at Children’s National, and Stephen ...
(Date:10/12/2017)... ... , ... Health Literacy Innovations (HLI), creator of the Health ... Cancer Patient Education Network (CPEN), an independent professional organization that shares best practices ... , As CPEN’s strategic partner, HLI will help support CPEN members by ...
Breaking Medicine News(10 mins):
(Date:10/10/2017)... 2017   West Pharmaceutical Services, Inc. (NYSE: ... drug administration, today shared the results of a study ... the intradermal administration of polio vaccines. The study results ... May 2017 by Dr. Ondrej Mach , Clinical ... Organization (WHO), and recently published in the journal ...
(Date:10/4/2017)... , Oct. 4, 2017  According to the Centers for Disease Control ... of October . PhysicianOne Urgent Care is helping communities across ... NY , by offering no-cost* flu shots through the end of ... by certain health insurance regulations. ... best time to get a flu shot is by the end of ...
(Date:10/2/2017)... 2, 2017  AllianceRx Walgreens Prime, the combined central ... and pharmacy benefit manager Prime Therapeutics LLC (Prime), today ... included the unveiling of new signage at its headquarters ... as at a few other company-owned facilities across the ... patients, some of whom will begin to see the ...
Breaking Medicine Technology: